The FARS2 gene helps mitochondria, the parts of your cells that make energy, build proteins they need to work. If it does not work properly, cells can struggle to produce enough energy, especially in the brain and muscles. This gene plays an important role in keeping high energy tissues working day to day. More disruptive variants in the FARS2 gene can cause a mitochondrial condition linked to seizures, developmental delay, muscle weakness or stiffness, and movement problems.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or manage processes in the body. Some genes provide the instructions for producing proteins, which do much of the work inside cells. Others mainly regulate when certain processes happen, where they take place, and how active they are. Together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
FARS2Gene function
What if the gene works
The FARS2 gene helps mitochondria, your cells’ energy makers, build certain proteins. This supports energy production, especially in tissues with high energy needs such as the brain and muscles.
Risk
What if the gene does not work
Variants in the FARS2 gene can disrupt energy production in mitochondria and may cause mitochondrial disease ranging from severe early-onset epilepsy with developmental delay to milder later-onset spastic weakness, often affecting walking.
Treatment
What does that mean for your treatment
No FARS2-specific treatment or drug-selection approach is currently established in clinical guidelines; care is supportive and guided by the person’s symptoms rather than the FARS2 variant itself. The FARS2 gene is being studied in mitochondrial disease research, but this has not yet led to a targeted therapy used in routine care.
Conditions associated with FARS2
Gene function
What if the gene works
Many cells need a steady flow of energy for everyday tasks like movement, signaling, and repair. The FARS2 gene supports that process inside mitochondria, the parts of cells that make most of the body’s usable energy. It does this by helping mitochondria make certain proteins they need for routine work.
Inside mitochondria, the FARS2 gene helps attach phenylalanine, a protein building block, to a matching transfer RNA, a small carrier molecule. This step gets the ingredient ready in the right form before a mitochondrial protein is made.
This gene supports protein making inside mitochondria, the parts of cells that produce most usable energy. By preparing phenylalanine correctly, it helps the mitochondria’s protein making machinery build proteins in the proper order.
Many proteins made with help from the FARS2 gene are needed for the cell’s energy system. This is part of what the FARS2 gene does in the body, helping mitochondria keep everyday energy production moving.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These differences are common and help create normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FARS2 gene can change the shape or stability of a mitochondrial enzyme, so it cannot properly attach phenylalanine to transfer RNA (a molecule that helps build proteins). This is how variants influence the FARS2 gene's function: mitochondrial protein production becomes less efficient, and cells may make less energy. Some variants leave partial activity, while more disruptive variants can sharply reduce or abolish it, which often links to earlier onset or more severe mitochondrial disease.
How variants are linked to conditions
Pathogenic variants in the FARS2 gene cause a rare inherited mitochondrial condition, often described as FARS2 gene variants and mitochondrial disease. The main well-established presentations are infantile developmental and epileptic encephalopathy and a later-onset condition with spastic paraplegia that affects walking. Some people also have developmental delay, low muscle tone, or high lactate levels on testing. Finding disease-causing variants in both copies of the FARS2 gene can confirm the diagnosis.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely seen in the general population. Most do not directly affect health and simply reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a certain diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-understood variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FARS2, risk is mainly set by the genetic changes inherited, especially whether both copies of the gene are affected. There is not enough evidence to say that lifestyle or environmental factors change the chance of having a FARS2-related condition.
Inheritance of FARS2 variants
FARS2-related conditions are inherited in an autosomal recessive pattern. This means a child usually inherits one altered copy of the FARS2 gene from each parent. When both parents carry one FARS2 variant, each pregnancy has a 25% chance of producing a child with the condition, a 50% chance of producing a child who is a carrier, and a 25% chance of producing a child with two working copies. In families asking how FARS2 variants are inherited, boys and girls are affected equally because the FARS2 gene is not on a sex chromosome.
What does my FARS2 result mean for my family?
Changes in the FARS2 gene are usually passed down in a recessive way, so close relatives may also be carriers even if they have no symptoms. Brothers and sisters of an affected child may have a chance of also being affected or of being carriers. For many families, this means parents, siblings, and sometimes other relatives may want to learn whether the same gene change runs in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the FARS2 gene, clinicians use FARS2 genetic testing on a blood sample or cheek swab. A lab reads the gene's DNA code and compares it with the usual sequence to identify changes, which can help confirm or rule out a suspected FARS2 related condition.
When should I consider getting a genetic test?
Genetic testing for the FARS2 gene may be considered when a baby or child has unexplained seizures, developmental delay, muscle stiffness or weakness, or signs of a cell-energy condition. It can also help if there is a known FARS2 variant or a family history of a similar condition.
A genetic result is only one part of your health story
A genetic result can be helpful, but how much it can tell you varies based on the condition and the kind of variant involved. Many factors, including lifestyle, environment, age, and medical history, also influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug faster or slower than expected, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, seem less helpful for another, or cause side effects more easily in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes can affect the way they respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently in different people. With many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can help guide treatment choices that are better informed and more personalized. More detail on this topic is available in the LearnHub.
Drugs influenced by the FARS2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how someone will respond to medicines. Questions about side effects, medicine safety, or changes in symptoms are best discussed with your doctor, especially before starting a new treatment or if a medicine seems to make you feel worse.
History
The FARS2 gene entered the medical literature as researchers worked to catalog genes involved in mitochondrial disease, a growing focus in the early 2000s. Initially understood through laboratory studies, it became much more clinically relevant when doctors began linking inherited FARS2 variants to children with early neurologic symptoms, including epilepsy and developmental difficulties. From these first observations, research expanded steadily, and clinicians recognized that FARS2 related conditions can look quite different from one person to another. Later case reports and genetic testing studies helped define a broader picture, including forms associated with movement problems and spasticity. This history has made FARS2 an established part of modern mitochondrial genetics, even though it remains a rare cause of disease.